FDA Rejects Nuplazid Application for Treatment of Alzheimer’s Disease Psychosis
The FDA has rejected an application to approve Nuplazid to treat Alzheimer's disease psychosis.
The FDA has rejected an application to approve Nuplazid to treat Alzheimer's disease psychosis.
A new study finds that Roundup weed killer's active ingredient, glyphosate, passes through the blood-brain barrier, potentially increasing the risk of Alzheimer's and other neurodegenerative diseases.
A new study links combination hormone therapy for women going through menopause with an increased risk of Alzheimer's disease.
A new study warns that the use of antipsychotics and some Alzheimer's disease drugs can increase the risk of elderly falls and fractures.
A new study warns that the FDA fails to rely on previous experience in dealing with the approval of drugs with questionable effectiveness, which could erode public trust.
Two powerful House committee chairs are calling on the FDA to provide a raft of information on how and why it approved the controversial new Alzheimer's drug Aduhelm.
The FDA's Acting Commissioner has asked the Office of the Inspector General to investigate the agency's controversial decision to approve the new Alzheimer's disease drug, Aduhelm, following a wave of…
Two members of an FDA advisory committee have resigned in protest over the approval of a new Alzheimer's disease drug, which many critics say shows no evidence of actually being…
The FDA faces criticism for the rushed approval of a new Alzheimer's disease drug, which its own advisors say has not been shown to be effective.
Traumatic brain injuries' effects on the brain are very similar to those of Alzheimer's disease, according to the findings of a new study.